The Benefits Of Tablet Tooling Standardisation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Benefits Of Tablet Tooling Standardisation
A global tablet tooling standard would offer many benefits for tablet manufacturers but has been slow to emerge. Currently, there are several standards available, but calls for a single, global solution should be endorsed.


Pharmaceutical Technology Europe
Volume 23, Issue 3


Getty/ Dominik Pabis
Tooling standardisation in the tablet manufacturing industry is a topic that has concerned tabletting professionals for decades. I Holland, authors of the Eurostandard, the most widely adopted tooling standard globally, have been striving for some time to promote a consensus in this area.

Why was a standard needed?

Conception of the Eurostandard began in the 1970s when conversion from Imperial measurements (inches) to metric measurements (millimetres) first began to take effect, creating a recognised need to reduce variables in tooling specifications/standards set by original equipment manufacturers (OEMs).

As European tablet press manufacturers started to gain ground in the 1980s against UK press manufacturer Manesty's former market domination, German DIN standards began to be applied to tablet tooling. DIN standards were designed for general engineering components, limits and fits, but the clearances created by this system are not always appropriate for tablet tooling. This is because the powder compaction process is very different to typical mechanical processes that benefit from contact lubrication using general engineering components. Therefore, this system did not address the issues that a dedicated tooling standard should have done.

In 1990, I Holland invited prominent tablet press and tooling manufacturers to come together to formulate a dedicated standard. Unfortunately, this received little or no interest from the other parties — possibly due to fears of losing a competitive advantage. Despite this, the first edition of the Eurostandard was developed and published in 1992. By the time the 2nd edition was released in 1996, the Eurostandard had been adopted as the accepted standard for the vast majority of tablet tooling markets outside North America.


The author says…
Simultaneously, during the midnineties a group of French pharmaceutical companies and tooling manufacturers contacted the International Organisation for Standardisation (ISO), to investigate the possibility of establishing a European standard for tablet tooling. This exercise culminated in the formulation of the internationally acknowledged ISO 18084.2005 (E) for punches and dies.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here